Efficacy of Neoadjuvant Toripalimab Plus Chemotherapy and the Role of Dynamic Monitoring of Plasma Cell-Free DNA Methylation in Predicting Pathological Response in Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer (RENAISSANCE Study): a Prospective Phase II Trial
crossref(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined